PHARMACYTE BIOTECH, INC. Proceeds from Contributed Capital
PHARMACYTE BIOTECH, INC. (PMCB) reported Proceeds from Contributed Capital of $0 for the 9-month period ending 2012-01-31, per its 10-Q filed 2012-03-21.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromContributedCapital · last filed 2012-08-14
- PHARMACYTE BIOTECH, INC. proceeds from contributed capital for the quarter ending 2011-04-30 was $28.23K.
- PHARMACYTE BIOTECH, INC. proceeds from contributed capital for fiscal 2011 was $64.29K.
| Period end | Proceeds from Contributed Capital 3 month | Proceeds from Contributed Capital 9 month | Proceeds from Contributed Capital 12 month |
|---|---|---|---|
| 2012-01-31 | $0.00 10-Q · filed 2012-03-21 | ||
| 2011-04-30 | $28.23K derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-14 | $64.29K 10-K · filed 2012-08-14 | |
| 2011-01-31 | $36.06K 10-Q · filed 2012-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |